MARK GARBEK: Open Payments
NPI 1679104624 · BLOOMINGTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$234 in 12 payments from 7 companies in 2025. Trend: 2023 $394 · 2024 $280 · 2025 $234
Food & beverage: $234
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $93 |
| Paratek Pharmaceuticals, Inc. | 2 | $42 |
| Novo Nordisk Inc | 1 | $26 |
| SCPHARMACEUTICALS INC. | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $18 |
| Boston Scientific Corporation | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: ELIQUIS, NUZYRA, Rybelsus, FUROSCIX, NURTEC ODT, Veklury, WATCHMAN FLX, ZERBAXA.
Industry payments across IL — which companies pay providers there.
